Position in PFE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$37,303,044
+$3,366,087 QoQ
Shares Held
1,328,456
-2.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. PFE ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
This page
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,303,044 | 1,328,456 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,936,957 | 1,362,930 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $35,942,546 | 1,410,618 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $35,113,773 | 1,448,588 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $37,299,973 | 1,471,980 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $39,795,689 | 1,500,026 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $42,645,260 | 1,473,575 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $42,293,001 | 1,511,544 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $36,691,050 | 1,322,200 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $39,465,879 | 1,370,819 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $46,326,217 | 1,396,630 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $52,563,026 | 1,433,016 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $59,139,477 | 1,449,497 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $75,161,496 | 1,466,852 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $65,228,918 | 1,490,606 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $79,299,378 | 1,512,481 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $79,036,068 | 1,526,677 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $73,229,026 | 1,240,119 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $59,246,619 | 1,377,508 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $50,821,926 | 1,297,802 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $52,243,986 | 1,442,009 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $49,689,414 | 1,349,889 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $51,707,092 | 1,408,914 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $47,506,511 | 1,452,797 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $46,560,603 | 1,426,491 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||